OakChart

Tilray Brands Inc

TLRYHealthcare·Drug Manufacturers - Specialty & Generic·Canada·Small·NASD·Nov 13 • 7:25 AM ET

2.51+0.02 (0.80%)
2026-11-13 13:29 CET
Market cap
$370.95M
Revenue, TTM
963.10 USD m
Net income, TTM
-164.22 USD m
Free cash flow, TTM
-119.23 USD m
EPS diluted, TTM
-1.40
-
Compare

Price

TLRY against its 20, 50 and 200-day averages
Terms2050200Miss
Patternshover a marker to name it
RS 0Sales 265Price2652714.006.008.0010.006.4M12.7MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26TLRYclose 2.5120-day 2.7550-day 3.40200-day 5.172.51

84.0% under the 52-week high of 15.70 on 18 Dec 2025. 52-week low 2.47 on 12 Nov 2026. Last 15 sessions, 21.5% high to low

Volume 0.01× normal · the line is the 50-bar volume average

Setup. RS line 0
CANSLIM 2 of 6 — fails: EPS Growth Qtr Over Qtr: High (>25%); 52-Week High/Low: 0-10% below High; Performance: Year +50%; Institutional Ownership: Over 50%
VCP 3 of 6 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High
Minervini 0 of 4 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High; Performance: Year +50%
Zanger 0 of 5 — fails: RSI (14): Not Oversold (>50); Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5; 200-Day Simple Moving Average: Price above SMA200
Leaders 1 of 5 — fails: 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%; 52-Week High/Low: 0-10% below High
Breakout 0 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2; 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200
Growth 2 of 4 — fails: EPS Growth Qtr Over Qtr: High (>25%); Return on Equity: Over +15%
Quality 1 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 25
Value 1 of 4 — fails: Return on Equity: Over +15%; Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 15
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 1 of 4 — fails: Float: Under 100M; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%
Accumulation 0 of 4 — fails: Institutional Ownership: Over 30%; Institutional Transactions: Over +10%; 200-Day Simple Moving Average: Price above SMA200; Performance: Year Up
Relative Strength 1 of 3 — fails: Performance: Year +100%; 200-Day Simple Moving Average: Price above SMA200

Profile

TLRY
52-week range, 0% of the way up
2.4715.70

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Employees3595
IPOJul 19, 2018
Beta2.05
ATR, 14d0.17
Rel volume0.01
Short float13.43%
Insider own1.59%
Inst own10.50%

Snapshot

6 groups

Valuation

Index-
Market Cap$370.95M
Enterprise Value504.81M
Income-164.22M
Sales963.10M
Book / share11.29
Cash / share1.50
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees3595
IPOJul 19, 2018

Ratios

Price / earnings-
Forward price / earnings-
Price / earnings / growth-
Price / sales0.39
Price / book0.22
Price / cash1.68
Price / free cash flow-
Value / cash profit49.64
Value / sales0.52
Quick Ratio1.11
Current Ratio1.88
Debt / equity0.23
Long-term debt / equity0.17
Options and shortYes / Yes

Earnings

Earnings / share-1.40
Earnings next year-0.21
Earnings next quarter-0.16
Earnings this year48.39%
Earnings next year63.43%
Earnings growth, 5 years67.72%
Past earnings growth64.12% 39.71%
Past sales growth13.44% 12.28%
Earnings vs last year93.85%
Sales vs last year15.93%
Earnings vs last quarter-10683.33%
Sales vs last quarter22.74%
EarningsOct 08 BMO
Surprise-76.41% -3.42%

Ownership

Insiders own1.59%
Insider trades0.64%
Institutions own10.50%
Institution trades2.72%
Return on assets-7.45%
Return on equity-10.38%
Return on capital-8.64%
Gross Margin26.82%
Operating margin-6.28%
Profit Margin-17.05%
20-day average-8.84%
50-day average-26.23%
200-day average-51.44%

Technical

Shares out147.79M
Shares floating145.44M
Short / float13.43%
Short ratio4.66
Short interest19.54M
52-week high15.70 -84.0%
52-week low2.47 +1.6%
Volatility6.25% 5.67%
Average range0.17
Strength index32.94
Market sensitivity2.05
Relative volume0.01
Avg Volume4.19M
Volume1,821

Performance

Perf Week-14.04%
Perf Month-21.81%
Perf Quarter-43.97%
Perf Half Y-52.82%
Perf YTD-72.20%
Perf Year-77.79%
Perf 3Y-85.06%
Perf 5Y-98.06%
Perf 10Y-
Recommendation2.40
Target Price5.72
Prev Close2.49
Price2.51
Change %0.80%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Apr 02, 2026UpgradeRoth CapitalNeutral → Buy$10+298.4%
Jan 27, 2026InitiatedCanaccord GenuityHold
Apr 05, 2024ReiteratedAlliance Global PartnersNeutral$2.25 → $2.75+9.6%
Nov 02, 2022InitiatedBernsteinMkt Perform$3.90+55.4%
Jul 29, 2022DowngradeThe Benchmark CompanyHold → Sell$3+19.5%
Mar 04, 2022UpgradeCanaccord GenuityHold → Buy$9+258.6%
Nov 18, 2021InitiatedBarclaysUnderweight$10+298.4%
Nov 01, 2021DowngradeCantor FitzgeraldOverweight → Neutral$18 → $11.80+370.1%
Jun 11, 2021DowngradeCIBCSector Outperform → Neutral$25+896.0%
Jun 03, 2021UpgradeCantor FitzgeraldNeutral → Overweight$30.25 → $22+776.5%

Peers

Mkt cap
TickerCompanyMkt cap
CGCCanopy Growth Corp245.54M
ACBAurora Cannabis Inc328.09M
CRONCronos Group Inc1.24B
OGIOrganigram Global Inc117.04M
GLASGlass House Brands Inc96.79M
SNDLSNDL Inc335.79M
TRLVTrulieve Cannabis Corp2.11B
HITIHigh Tide Inc222.85M
VFFVillage Farms International Inc310.69M
SAMBoston Beer Co Inc2.23B

Insider trading

latest 14 of 24
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
SIMON IRWIN DPresident and CEOAug 26 '26Option Exercise0.001,212,16801,734,920Aug 27 08:00 PM
Merton Carl AChief Financial OfficerAug 26 '26Option Exercise0.00168,4520276,646Aug 27 08:00 PM
Gendel MitchellGlobal General CounselAug 26 '26Option Exercise0.00160,3040258,392Aug 27 07:59 PM
FALTISCHEK DENISE MChief Strategy OfficerAug 26 '26Option Exercise0.00178,2210288,657Aug 27 07:59 PM
Gendel MitchellGlobal General CounselAug 06 '26Buy4.432,50011,075124,883Aug 07 09:29 AM
Merton Carl AChief Financial OfficerAug 04 '26Buy4.6210,00046,200139,753Aug 04 01:36 PM
FALTISCHEK DENISE MChief Strategy OfficerAug 03 '26Buy4.782,50011,950141,285Aug 04 10:58 AM
SIMON IRWIN DPresident and CEOJul 30 '26Option Exercise0.00117,6470801,666Jul 31 05:53 PM
SIMON IRWIN DPresident and CEOJul 29 '26Option Exercise0.00428,4480911,097Jul 31 05:53 PM
Merton Carl AChief Financial OfficerJul 30 '26Option Exercise0.0016,6560138,914Jul 31 05:53 PM
Merton Carl AChief Financial OfficerJul 29 '26Option Exercise0.0060,4170152,467Jul 31 05:53 PM
Gendel MitchellGlobal General CounselJul 30 '26Option Exercise0.0024,3790135,304Jul 31 05:53 PM
Gendel MitchellGlobal General CounselJul 29 '26Option Exercise0.0087,4400157,269Jul 31 05:53 PM
FALTISCHEK DENISE MChief Strategy OfficerJul 30 '26Option Exercise0.0026,1200152,629Jul 31 05:52 PM

Held by

AUM
TickerCompanyAUM
MJAmplify Alternative Harvest ETFAUM: 98.28M
VHTVanguard Health Care ETFAUM: 21.54B
SMLFiShares U.S. Small-Cap Equity Factor ETFAUM: 4.31B
FHLCFidelity MSCI Health Care Index ETFAUM: 4.13B
PDNInvesco RAFI Developed Markets ex-U.S. Small-Mid ETFAUM: 341.85M
ISCViShares Morningstar Small-Cap Value ETFAUM: 702.02M
SPDWState Street SPDR Portfolio Developed World ex-US ETFAUM: 41.93B
WSMLiShares MSCI World Small-Cap ETFAUM: 676.68M
MSMLiShares MSCI USA Small-Cap ETFAUM: 280.85M

News

latest 14 of 200
  • 10 Barrel Brewing, Widmer Brothers and Hop Valley Named Official Craft Beer Partners of the Portland Trail Blazers (GlobeNewswire)
  • Whiskey You Won't Find on Shelves: Breckenridge Distillery Launches the 2 Mile High Whiskey Club (GlobeNewswire)
  • Aurora Cannabis Record International Medical Revenue Quarterly Update Report (Exec Edge) -7.02%
  • Tilray Brands targets $20M in cost savings after craft brewery closures (Food Dive)
  • Tilray Brands Consolidates Canadian Cannabis Operations and Raises FY2027 EBITDA Guidance (InvestorsHub)
  • Tilray Brands Announces Strategy to Strengthen Canadian Cannabis Operations and Drive Profitable Growth (GlobeNewswire)
  • Tilrays beverage business poised for volume growth as Carlsberg deal date nears, says Jefferies (Proactive)
  • Breckenridge Distillery and University of Denver Athletics Release Limited-Edition Whiskey Celebrating Record 11th NCAA Men's Hockey Championship (GlobeNewswire)
  • Tilray Brands Announces Next Phase of Beverage Transformation (GlobeNewswire)
  • Blue Point Brewing Co.'s Legendary Cask Ales Festival Returns to Patchogue with 100+ Limited-Release Brews (GlobeNewswire)
  • West Ham United F.C. and BrewDog Unveil Boleyn Brew: A Fan-Created Matchday Beer Made by Hammers, for Hammers (GlobeNewswire)
  • SweetWater Brewing Gives Fans the Chance to Win Tickets to Their Dream Show at AEG Venues Across Georgia (GlobeNewswire)
  • Tilray Medical Strengthens Global Medical Cannabis Supply Chain with Approval to Bring Critical EU-GMP Quality Testing In-House, Accelerating Product Release Across Regulated Global Markets (GlobeNewswire)
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive) -5.08%

Quarterly earnings

2026Q1 EPS -0.320 missed -0.181, from 0.000 a year earlier. Sales 257.15 missed 266.26, from 209.5 a year earlier
EPS
0.0000-13.0002024Q2 EPS -1.000 against -0.33824Q22024Q3 EPS -8.700 against -0.37524Q32024Q4 EPS -13.000 against -0.23524Q42025Q1 EPS 0.000 against -0.26625Q12025Q2 EPS -0.410 against -0.21425Q22025Q3 EPS -0.224 against -0.13625Q32025Q4 EPS -0.430 against -0.01225Q42026Q1 EPS -0.320 against -0.18126Q1
Sales, USD millions
281.7102024Q2 sales 210.95 against 216.3424Q22024Q3 sales 185.78 against 206.8424Q32024Q4 sales 224.54 against 232.2324Q42025Q1 sales 209.5 against 204.5525Q12025Q2 sales 217.51 against 210.9425Q22025Q3 sales 206.73 against 201.3525Q32025Q4 sales 281.71 against 246.325Q42026Q1 sales 257.15 against 266.2626Q1

The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.

PeriodReportedEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mSurpriseYear-ago quarterAnalystsNext session
2026Q1ended 2026-08-312026-10-08 08:30-0.320-0.181-0.320257.15266.26EPS +76.4% · sales -3.4%vs 2025Q1, year-ago quarter · EPS - · sales +22.7%7 EPS · 9 salesOpen -6.06% vs SPY -0.30%. Close -3.36% vs SPY -0.42%
2025Q4ended 2026-05-312026-07-28 16:30-0.430-0.012-0.429281.71246.3EPS +3483.3% · sales +14.4%vs 2024Q4, year-ago quarter · EPS -96.7% · sales +25.5%5 EPS · 9 salesOpen 0.00% vs SPY -0.12%. Close -0.99% vs SPY -1.54%
2025Q3ended 2026-02-282026-04-01 08:30-0.224-0.136-0.236206.73201.35EPS +64.8% · sales +2.7%vs 2024Q3, year-ago quarter · EPS -97.4% · sales +11.3%5 EPS · 9 salesOpen +2.16% vs SPY +0.55%. Close -5.10% vs SPY +0.75%
2025Q2ended 2025-11-302026-01-08 16:30-0.410-0.214-0.407217.51210.94EPS +91.9% · sales +3.1%vs 2024Q2, year-ago quarter · EPS -59.0% · sales +3.1%3 EPS · 7 salesOpen +10.08% vs SPY +0.16%. Close +0.55% vs SPY +0.66%
2025Q1ended 2025-08-312025-10-09 08:300.000-0.266-0.003209.5204.55EPS -100.0% · sales +2.4%vs 2024Q1, year-ago quarter · EPS -100.0% · sales +4.8%4 EPS · 8 salesOpen +15.70% vs SPY +0.06%. Close +22.09% vs SPY -0.29%
2024Q4ended 2025-05-312025-07-28 16:30-13.000-0.235-13.015224.54232.23EPS +5431.9% · sales -3.3%vs 2023Q4, year-ago quarter · EPS +3150.0% · sales -2.3%5 EPS · 8 salesOpen -14.25% vs SPY +0.22%. Close -17.55% vs SPY -0.26%
2024Q3ended 2025-02-282025-04-08 08:30-8.700-0.375-8.691185.78206.84EPS +2220.0% · sales -10.2%vs 2023Q3, year-ago quarter · EPS +625.0% · sales -1.4%7 EPS · 9 salesOpen -1.02% vs SPY +3.47%. Close -21.23% vs SPY -1.57%
2024Q2ended 2024-11-302025-01-10 08:30-1.000-0.338-0.987210.95216.34EPS +195.9% · sales -2.5%vs 2023Q2, year-ago quarter · EPS +42.9% · sales +8.9%8 EPS · 10 salesOpen -9.49% vs SPY -0.61%. Close -10.22% vs SPY -1.53%
2024Q1ended 2024-08-312024-10-10 08:30-0.400-0.350-0.447200218.7EPS +14.3% · sales -8.6%vs 2023Q1, year-ago quarter · EPS -60.0% · sales +13.0%8 EPS · 10 salesOpen -0.61% vs SPY -0.24%. Close -2.45% vs SPY -0.18%
2023Q4ended 2024-05-312024-07-29 16:30-0.400-0.229-0.400229.88226.2EPS +74.7% · sales +1.6%vs 2022Q4, year-ago quarter · EPS -73.3% · sales +24.8%7 EPS · 11 salesOpen +10.93% vs SPY +0.28%. Close +9.84% vs SPY -0.51%
2023Q3ended 2024-02-292024-04-09 08:30-1.200-0.500-1.229188.34197.18EPS +140.0% · sales -4.5%vs 2022Q3, year-ago quarter · EPS -93.7% · sales +29.4%9 EPS · 11 salesOpen -18.15% vs SPY +0.34%. Close -20.66% vs SPY +0.12%
2023Q2ended 2023-11-302024-01-09 08:30-0.700-0.513-0.671193.77193.68EPS +36.5% · sales +0.0%vs 2022Q2, year-ago quarter · EPS -36.4% · sales +34.4%8 EPS · 12 salesOpen +5.56% vs SPY -0.58%. Close -9.83% vs SPY -0.15%
2023Q1ended 2023-08-312023-10-04 08:30-1.000-0.513-1.035176.95174.3EPS +94.9% · sales +1.5%vs 2022Q1, year-ago quarter · EPS -23.1% · sales +15.5%8 EPS · 13 sales-
2022Q4ended 2023-05-312023-07-26 08:30-1.500-0.413-2.112184.19153.96EPS +263.2% · sales +19.6%vs 2021Q4, year-ago quarter · EPS -83.3% · sales +8.9%8 EPS · 13 sales-
2022Q3ended 2023-02-282023-04-10 16:30-19.000-0.557-19.024145.59150.02EPS +3311.1% · sales -3.0%vs 2021Q3, year-ago quarter · EPS -2211.1% · sales -4.1%7 EPS · 13 sales-
2022Q2ended 2022-11-302023-01-09 08:30-1.100-0.567-1.136144.14154.79EPS +94.0% · sales -6.9%vs 2021Q2, year-ago quarter · EPS -973.0% · sales -7.1%12 EPS · 13 sales-

Annual earnings

2025FY EPS -1.090 missed -0.642, from -24.600 a year earlier. Sales 915.45 beat 877.98, from 821.31 a year earlier
EPS
0.0000-32.0002018FY EPS -8.200 against -5.71720182019FY EPS -32.000 against -14.15020192020FY EPS -21.500 against -24.28820202021FY EPS -9.000 against -0.76420212022FY EPS -23.500 against -22.22220222023FY EPS -3.300 against -3.09620232024FY EPS -24.600 against -11.82420242025FY EPS -1.090 against -0.6422025
Sales, USD millions
915.4502018FY sales 43.13 against 41.8020182019FY sales 166.98 against 174.9820192020FY sales 210.48 against 208.0320202021FY sales 695.21 against 629.3320212022FY sales 627.12 against 598.2620222023FY sales 788.94 against 784.9620232024FY sales 821.31 against 829.8320242025FY sales 915.45 against 877.982025

Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.

earnings feed, not the snapshot. Not the statement ratio.

PeriodEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mP/E, earnings feed
2030FYestimate-0.185--1,20613.57
2029FYestimate-0.125--1,19820.08
2028FYestimate--0.037--1,183-
2027FYestimate--0.206--1,158-
2026FYestimate--0.563--1,104-
2025FY-1.090-0.642-1.090915.45877.98-
2024FY-24.600-11.824-24.561821.31829.83-
2023FY-3.300-3.096-3.299788.94784.96-
2022FY-23.500-22.222-23.506627.12598.26-
2021FY-9.000-0.764-9.908695.21629.33-
2020FY-21.500-24.288-13.631210.48208.03-
2019FY-32.000-14.150-31.971166.98174.98-
2018FY-8.200-5.717-8.15843.1341.80-

Quarterly results

2026Q1 revenue 257.15, from 209.5 a year earlier. Operating margin -6.3%, from -5.2% a year earlier
Revenue, USD millions
281.7102024Q2 revenue 210.9524Q22024Q3 revenue 185.7824Q32024Q4 revenue 224.5324Q42025Q1 revenue 209.525Q12025Q2 revenue 217.5125Q22025Q3 revenue 206.7325Q32025Q4 revenue 281.7125Q42026Q1 revenue 257.1526Q1
Operating margin
0.00-16.92024Q2 operating margin -16.2%24Q22024Q3 operating margin -16.9%24Q32024Q4 operating margin -5.6%24Q42025Q1 operating margin -5.2%25Q12025Q2 operating margin -9.2%25Q22025Q3 operating margin -9.6%25Q32025Q4 operating margin -1.6%25Q42026Q1 operating margin -6.3%26Q1

From the quarterly statement. Not an estimate.

Estimate revisions

Latest snapshot of each period and type. 2026FY E -0.56 per share.
PeriodTypeScaleDateMeanvs prior date
2026FYSUSD millions2026-10-301,104+0.1%
2026Q2S-2026-10-30264.71-0.1%
2026FYEper share2026-10-20-0.56-3.6%
2026FYRper share2026-10-20-0.56-3.6%
2026Q2Eper share2026-10-09-0.16-1.2%
2026Q2Rper share2026-10-09-0.16-1.2%
2026Q1Eper share2026-10-05-0.18+0.8%
2026Q1Rper share2026-10-05-0.18+0.8%
2026Q1S-2026-10-05266.26-0.1%
2025Q4Eper share2026-07-24-0.010.0%
2025Q4Rper share2026-07-24-0.010.0%
2025FYS-2026-07-24877.98+0.0%
2025Q4S-2026-07-24246.30.0%
2025FYEper share2026-07-17-0.64+0.4%
2025FYRper share2026-07-17-0.64+0.4%
2025Q3Eper share2026-04-01-0.140.0%
2025Q3Rper share2026-04-01-0.140.0%
2025Q3S-2026-03-25201.350.0%
2025Q2S-2025-12-24210.940.0%
2025Q2Eper share2025-12-23-0.210.0%
2025Q2Rper share2025-12-23-0.210.0%
2025Q1S-2025-08-22204.550.0%
2025Q1Eper share2025-07-29-0.03-38.9%
2025Q1Rper share2025-07-29-0.03-38.9%
2024FYEper share2025-07-24-1.18-1.8%
2024FYRper share2025-07-24-1.18-1.8%
2024FYS-2025-07-24829.83-0.6%
2024Q4Eper share2025-07-21-0.02+4.4%
2024Q4Rper share2025-07-21-0.02+4.4%
2024Q4S-2025-07-21232.23-2.6%
2024Q3S-2025-04-04209.97-0.3%
2024Q3Eper share2025-03-30-0.040.0%
2024Q3Rper share2025-03-30-0.040.0%
2024Q2Eper share2024-12-24-0.030.0%
2024Q2Rper share2024-12-24-0.030.0%
2024Q2S-2024-12-24216.340.0%
2024Q1Eper share2024-10-07-0.04+3.1%
2024Q1Rper share2024-10-07-0.04+3.1%
2024Q1S-2024-10-07218.7-0.1%
2023FYEper share2024-07-17-0.310.0%
2023FYRper share2024-07-17-0.310.0%
2023FYS-2024-07-17784.960.0%
2023Q4S-2024-07-15226.20.0%
2023Q4Eper share2024-06-24-0.02+5.5%
2023Q4Rper share2024-06-24-0.02+5.5%
2023Q3S-2024-04-08197.18-0.6%
2023Q3Eper share2024-03-24-0.050.0%
2023Q3Rper share2024-03-24-0.050.0%
2022FYEper share2023-07-06-2.22-
2022FYRper share2023-07-06-2.22-
2022FYS-2023-07-06598.26-

Estimate history

Annual
Metric201720182019202020212022202320242025TTMMRQ
EPS per share-0.838-8.158-31.971-13.631-9.908-23.506-3.299-24.561-1.086-1.3957-
Sales USD millions2143167513628627789821915963-
Shares million shares991045536683106131-144
Quarterly
MetricQ1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
EPS per share-0.447-0.987-8.691-13.015-0.003-0.407-0.236-0.429-0.324
Sales USD millions200211186225210218207282257
Shares million shares889397106112116116131144

Income statement, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY5/31/20262024FY5/31/20252023FY5/31/20242022FY5/31/20232021FY5/31/20222020FY5/31/20212020FY12/31/20202019FY12/31/2019
Total Revenue963.10915.45+11.5%821.31+4.1%788.94+25.8%627.12-0.2%628.37+22.5%513.09+207.3%210.48+26.1%166.98
Cost of Goods Sold Incl. D&A704.78674.60+0.8%669.36+2.9%650.34+13.4%573.65-8.5%626.75+47.4%425.12+110.4%199.01-1.5%202.08
Gross Profit258.32240.86+58.5%151.95+9.6%138.60+159.2%53.47+3180.4%1.63-98.1%87.9611.48-35.10
Selling, General and Administrative Excl. Other318.83296.12+14.0%259.77+3.3%251.36+8.5%231.67+0.4%230.86+47.5%156.52-13.7%138.79-23.5%181.45
Research and Development0.410.36+28.6%0.28-56.3%0.64-5.9%0.68-55.3%1.52+83.1%0.83-87.3%4.41-32.8%6.56
Other Operating Expense0.000.000.000.00-100.0%6.500.000.000.000.00
Operating Income-60.51-55.26-107.81-112.76-184.69-229.24-68.56-127.31-216.56
Interest Expense23.4529.91-27.6%41.33-16.1%49.26+5.7%46.61+17.5%39.68+28.4%30.90-10.9%39.22+13.1%34.69
Unusual Expense29.1312.10-99.4%2,171.80+2386.0%87.36-92.8%1,216.25+688.4%154.27-33.7%232.83+188.7%109.43+35.7%80.64
Net Income Before Taxes-125.59-88.06-2,302.37-249.02-1,450.18-440.67-344.53-270.69-325.12
Income Taxes21.1117.10-121.02-26.62-7.18-6.54-8.97-5.60-8.45
Consolidated Net Income-146.70-105.16-2,181.36-222.40-1,443.00-434.13-336.01-271.07-321.17
Net Income From Continuing Operations-164.22-121.40-2,186.74-244.98-1,452.66-476.80-367.42-271.07-321.17
Net Income-164.22-121.40-2,186.74-244.98-1,452.66-476.80-367.42-271.07-321.17
EPS (Recurring) per share-1.08-1.01-7.49-2.48-9.73-7.66-7.58-1.54-26.35
EPS (Basic, Before Extraordinaries) per share-1.40-1.09-24.56-3.30-23.51-9.91-13.63-2.15-31.97
EPS (Diluted) per share-1.40-1.09-24.56-3.30-23.51-9.91-13.63-2.15-31.97
EBITDA10.1712.34-51.9%25.68+81.5%14.15-54.55-74.64-0.73-108.66-200.71
Non-Operating Income (Expense)-12.519.21-50.4%18.57+5058.3%0.36-2.62-17.49-12.23-280.6%5.27-22.2%6.77
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense37.5036.29+89.1%19.19-17.8%23.35-25.4%31.28+18.2%26.46+107.5%12.75-45.5%21.84-6.7%23.40
Price To Sales Ratio ratio0.630.670.461.691.653.448.764.9510.31
Gross Margin %26.8226.3118.5017.578.530.2617.145.45-21.02
Operating Margin %-6.28-6.04-13.13-14.29-29.45-36.48-13.36-60.49-129.69
Net Margin %-17.05-13.26-266.25-31.05-231.64-75.88-71.61-128.79-192.34
Shares Outstanding million shares143.81131.09+23.8%105.87+27.3%83.19+26.7%65.67+23.3%53.27+19.3%44.64+334.2%158.46+1441.4%10.28
Market Capitalization367.99367.99-11.2%414.53-72.3%1,497.47+36.6%1,096.61-54.1%2,391.71-92.0%29,859.13+1595.9%1,308.85-25.7%1,760.64

Income statement, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q18/31/20262025Q45/31/20262025Q32/28/20262025Q211/30/20252025Q18/31/20252024Q45/31/20252024Q32/28/20252024Q211/30/2024
Total Revenue257.15+22.7%281.71+25.5%206.73+11.3%217.51+3.1%209.50+4.7%224.53-2.3%185.78-1.4%210.95+8.9%
Cost of Goods Sold Incl. D&A186.14+19.4%197.38+11.1%156.880.0%164.37-4.8%155.96-3.8%177.61+6.6%156.95-2.2%172.66+2.6%
Gross Profit71.01+32.6%84.33+79.7%49.85+72.9%53.14+38.8%53.54+41.3%46.93-25.9%28.83+3.6%38.29+50.2%
Selling, General and Administrative Excl. Other87.13+35.3%88.84+49.1%69.72+15.8%73.15+1.0%64.41-4.6%59.59-29.0%60.23-1.6%72.44+20.4%
Research and Development0.09+125.0%0.18+500.0%0.06-33.3%0.08+33.3%0.04-63.6%0.03-92.3%0.09-18.2%0.060.0%
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-16.12-4.51-19.87-20.01-10.87-12.66-31.40-34.15
Interest Expense6.48-3.3%6.63+67.0%4.97-40.7%5.37-30.9%6.70-31.9%3.97-58.0%8.38-1.6%7.77-10.0%
Unusual Expense7.9911.90-99.2%6.85-99.1%2.39-69.0%-9.05-243.7%1,430.40+18770.7%727.39+1236.4%7.71+62.7%
Net Income Before Taxes-38.31-24.07-23.26-39.96-0.77-1,393.04-792.33-83.24
Income Taxes1.7313.861.97+64.2%3.55+74.0%-2.29-357.3%-125.141.202.04
Consolidated Net Income-40.03-2751.0%-37.93-25.23-43.511.51-1,267.90-793.53-85.28
Net Income From Continuing Operations-43.14-49.57-26.57-44.93-0.32-1,272.80-789.44-85.34
Net Income-43.14-49.57-26.57-44.93-0.32-1,272.80-789.44-85.34
EPS (Recurring) per share-0.28-0.36-0.19-0.39-0.06-2.78-3.09-0.92
EPS (Basic, Before Extraordinaries) per share-0.32-0.43-0.24-0.41-0.00-13.01-8.69-0.99
EPS (Diluted) per share-0.32-0.43-0.24-0.41-0.00-13.01-8.69-0.99
EBITDA2.52-46.3%14.83-30.8%-3.13-246.3%-4.054.69+111.3%21.42+92.5%2.14-0.10
Non-Operating Income (Expense)-7.72-199.6%-1.03-101.9%8.42-12.197.75-35.3%53.99-25.16-33.61
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense5.20+30.3%11.76+144.0%10.84+239.8%9.70+69.6%3.99-26.9%4.82-9.6%3.19-49.9%5.72-11.7%
Price To Sales Ratio ratio0.630.701.031.071.760.510.811.40
Gross Margin %27.6129.9324.1124.4325.5620.9015.5218.15
Operating Margin %-6.27-1.60-9.61-9.20-5.19-5.64-16.90-16.19
Net Margin %-16.78-17.60-12.85-20.66-0.15-566.86-424.93-40.46
Shares Outstanding million shares143.81+29.0%131.09+23.8%116.23+19.4%116.20+25.5%111.51+27.4%105.87+27.3%97.38+25.8%92.56+26.3%
Market Capitalization367.99-74.8%659.02+59.0%916.91+28.1%906.56-22.7%1,460.97+2.7%414.53-72.3%715.71-46.6%1,173.10-11.6%

Balance sheet, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2025FY5/31/20262024FY5/31/20252023FY5/31/20242022FY5/31/20232021FY5/31/20222020FY5/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/2018
Cash & Short Term Investments234.63-8.5%256.36-1.6%260.52-41.9%448.53+7.8%415.91-14.9%488.47+404.7%189.70+96.0%96.79-81.3%517.59
Short Term Receivables189.17+55.7%121.49+19.5%101.69+17.9%86.23-9.5%95.28+6.1%89.79+108.6%41.16-4.4%43.04+146.1%17.49
Inventories301.19+11.2%270.88+7.5%252.09+25.7%200.55-18.3%245.53-4.3%256.43+191.9%93.64+6.6%87.86+442.0%16.21
Other Current Assets67.14+68.3%39.89-37.1%63.41+68.1%37.72-19.4%46.79-4.4%48.92+56.1%22.52-28.1%31.34+941.2%3.01
Total Current Assets792.13+15.0%688.63+1.6%677.71-12.3%773.03-3.8%803.50-9.1%883.61+241.1%347.02+34.0%259.03-53.3%554.30
Net Property, Plant & Equipment722.54+22.3%590.71+2.8%574.35+31.8%435.61-27.5%600.50-10.2%668.97+231.6%217.54+7.8%201.73+151.5%80.21
Total Investments and Advances6.55-35.3%10.13+28.9%7.86-93.2%115.77-8.3%126.20+389.3%25.79-27.6%23.67-33.6%35.63+110.7%16.91
Long-Term Note Receivable-0.00-100.0%32.00------
Intangible Assets795.80+2.8%773.77-73.5%2,924.35-2.0%2,982.63-23.9%3,919.18-11.7%4,438.71+1032.1%353.36-9.9%392.08+8632.3%4.49
Deferred Tax Assets28.04-33.8%42.34-62.7%113.63+25.7%90.43-----
Other Assets10.98-0.9%11.08+105.6%5.39+2350.0%0.22-29.0%0.31-96.3%8.29+5.5%4.36-44.5%7.86+948.0%0.75
Total Assets2,356.05+11.3%2,116.66-51.2%4,335.30-1.4%4,397.69-19.3%5,449.69-9.6%6,025.36+572.2%945.95+5.5%896.33+36.5%656.67
Short Term Debt Incl. Current Port. of LT Debt40.29+39.5%28.89-25.8%38.96-82.6%224.26+142.1%92.65+86.8%49.60+1149.4%4.41+11.1%3.97+744.7%0.47
Accounts Payable114.54+6.7%107.35+1.9%105.39+48.8%70.82+3.2%68.60+18.9%57.71+47.7%17.78-54.5%39.06+266.8%10.65
Income Tax Payable12.67+21016.7%0.06-98.5%4.09-72.6%14.93+142.8%6.15-58.3%14.76---
Other Current Liabilities190.88+32.5%144.01-4.5%150.73+22.6%122.96+8.9%112.94-59.5%279.17+465.1%159.09+222.0%49.40+233.3%14.82
Total Current Liabilities358.38+27.9%280.30-6.3%299.17-30.9%432.98+54.4%280.34-30.1%401.24+334.1%181.28+96.1%92.43+256.3%25.94
Long Term Debt358.11+19.4%299.85-13.9%348.36-4.8%365.87-31.1%531.16-40.3%889.06+91.1%336.88-27.6%465.18+8.5%428.65
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities40.29-12.6%46.09-81.1%244.50-5.2%257.79+31.1%196.64-26.0%265.85+398.2%49.27-7.7%53.36+1107.2%4.42
Other Liabilities4.40+417.6%0.85+844.4%0.09-99.2%11.10+5742.1%0.19-95.1%3.91+4244.4%4.61+5022.2%0.090.00
Total Liabilities761.18+21.4%627.09-29.7%892.12-16.4%1,067.74+5.9%1,008.33-35.4%1,560.05+155.3%572.05-6.4%611.06+33.1%459.01
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity1,614.33+6.8%1,511.47-56.1%3,442.91+3.8%3,315.69-24.6%4,398.81-1.4%4,459.07+1463.1%373.90+31.1%285.27+44.3%197.65
Total Shareholders Equity1,614.33+6.8%1,511.47-56.1%3,442.91+3.8%3,315.69-24.6%4,398.81-1.4%4,459.07+1463.1%373.90+31.1%285.27+44.3%197.65
Accumulated Minority Interest-19.46-21.90-8211.1%0.27-98.1%14.25-66.5%42.56+582.1%6.240.000.000.00
Total Equity1,594.87+7.1%1,489.58-56.7%3,443.18+3.4%3,329.94-25.0%4,441.37-0.5%4,465.31+1465.3%373.90+31.1%285.27+44.3%197.65
Total Liabilities & Stockholders Equity2,356.05+11.3%2,116.66-51.2%4,335.30-1.4%4,397.69-19.3%5,449.69-9.6%6,025.36+572.2%945.95+5.5%896.33+36.5%656.67
Book Value Per Share per share12.31-13.8%14.28-65.5%41.38-18.0%50.49-38.9%82.58-17.3%99.88+259.8%2.36-91.5%27.76+30.9%21.21
Tangible Book Value Per Share per share6.24-10.5%6.97+11.9%6.23+22.9%5.07-43.7%9.00+1856.5%0.460.13-10.39-150.1%20.73
Full-Time Employees people3,595+26.5%2,842+7.2%2,650+65.6%1,600-5.9%1,700-19.0%2,100+27.6%1,030-37.4%1,646+139.2%688
Price to Book Ratio ratio0.220.150.430.330.5455.233.506.1733.25
Return on Assets %-5.43-67.79-5.61-29.50-8.31-10.62-29.43-41.36-19.06
Return on Equity %-7.77-88.27-7.25-37.66-10.77-15.49-82.25-133.01-70.25
Return on Invested Capital %-6.15-120.73-6.46-39.46-9.67-6.87-38.14-42.80-10.81
Quick Ratio ratio1.371.491.421.321.991.561.401.8520.75
Current Ratio ratio2.212.462.271.792.872.201.912.8021.37

Cash flow, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY5/31/20262024FY5/31/20252023FY5/31/20242022FY5/31/20232021FY5/31/20222020FY5/31/20212020FY12/31/20202019FY12/31/2019
Net Income-147.13-105.16-2,181.36-222.40-1,443.00-434.13-336.01-271.07-321.17
Depreciation70.9567.60-49.4%133.49+5.2%126.91-2.5%130.15-15.8%154.59+127.9%67.83+327.9%18.65+17.7%15.85
Other Funds (Non Cash)56.0238.67-98.2%2,136.85+1802.3%112.33-91.6%1,338.31+505.8%220.91-26.2%299.27+69.4%188.38+6.6%176.67
Funds from Operations1.0218.22-32.04-22.03-6.49-85.49-1474.4%6.22-69.42-137.50
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-85.64-87.36-62.56-8.87-161.6%14.40-91.77-50.94-59.94-120.57
Cash from Operating Activities-84.62-69.14-94.60-30.91-490.8%7.91-177.26-44.72-129.35-258.07
Capital Expenditures-34.61-32.99-32.92-29.25-20.80-34.06-38.87-44.64-78.62
Net Assets From Acquisitions-54.64-53.70-18.11-60.63-26.720.000.000.00-163.89
Sale of Fixed Assets and Businesses3.333.51-48.5%6.82-19.9%8.51+97.9%4.30-65.7%12.53-82.9%73.22+1012.8%2.66-59.6%6.58
Purchase or Sale of Investments-3.8327.38-2.52-101.2%209.72-241.900.000.000.30-14.57
Purchase of Investments-3.61-4.60-2.520.00-241.900.000.00-3.76-1,398.20
Sale Or Maturity of Investments-0.2231.970.00-100.0%209.720.000.000.00-100.0%4.07-99.7%1,383.63
Other Uses0.000.000.000.000.000.00-2.420.00-2.69
Other Sources0.000.000.000.000.000.00-100.0%14.180.000.00
Cash from Investing Activities-89.75-55.80-46.72-136.4%128.35-285.11-21.53-146.7%46.11-41.68-253.18
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock160.84160.34-0.5%161.19+1770.0%8.62-93.3%128.40-51.1%262.51+155.6%102.69-7.9%220.20+97.5%111.52
Repurchase of Common Pref Stock0.000.000.000.00-1.190.000.00-1.26-5.01
Sale of Common Pref Stock160.84160.34-0.5%161.19+1770.0%8.62-93.3%129.59-50.6%262.51+155.6%102.69-11.9%221.47+90.1%116.53
Proceedsfrom Stock Options158.46157.97-2.0%161.19+1770.0%8.62-93.3%129.59-50.6%262.51+156.0%102.55-7.7%209.97+89.0%111.07
Issuance or Reduction of Debt, Net-28.14-23.76-23.24-80.91-57.13-118.87-355.3%46.57+1162.1%44.79+1113.8%3.69
Change in Long Term Debt-28.65-25.35-12.39-75.56-62.39-128.28-435.5%38.24+936.3%44.79+1113.8%3.69
Issuance of Long Term Debt0.000.00-100.0%3.45-93.6%54.17-63.0%146.340.00-100.0%102.80+2353.5%46.40+1007.4%4.19
Reduction of Long Term Debt-28.65-25.35-15.84-129.73-208.73-128.28-64.56-1.61-0.50
Net Financing Active Other Cash Flow-0.16-0.16-1.540.000.00-10.77-23.90-0.150.00
Other Financing Activities Uses-0.16-0.16-1.540.000.00-10.77-23.90-1.500.00
Cash from Financing Activities125.64130.99-1.9%133.51-75.19-207.2%70.16-45.3%128.20+3.1%124.31+8.4%264.85+130.9%114.70
Exchange Rate Effect2.271.63+43.0%1.14-0.55-2.23-1.96-192.5%2.12-65.1%-0.91-115.0%6.08
Net Change in Cash-46.457.68-6.67-130.7%21.71-209.28-72.56-156.8%127.8292.91-390.46
Free Cash Flow-119.23-102.13-127.52-60.15-12.89-211.33-83.59-174.00-331.81
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-17.10-121.02-38.87-31.95-27.54-24.87-5.38-8.85

Balance sheet, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q18/31/20262025Q45/31/20262025Q32/28/20262025Q211/30/20252025Q18/31/20252024Q45/31/20252024Q32/28/20252024Q211/30/2024
Cash & Short Term Investments221.39-16.4%234.63-8.5%264.82+6.6%291.55+15.6%264.83-5.4%256.36-1.6%248.41+10.0%252.25-3.5%
Short Term Receivables190.62+78.0%189.17+55.7%118.37+14.5%109.07-3.3%107.08+2.9%121.49+19.5%103.37+15.4%112.74+24.4%
Inventories328.97+16.3%301.19+11.2%292.30+11.0%283.20+6.5%282.79+7.0%270.88+7.5%263.40+7.9%266.01+5.3%
Other Current Assets66.61+43.4%67.14+68.3%43.27-39.2%45.50-40.4%46.45-40.1%39.89-37.1%71.11-0.8%76.34+104.3%
Total Current Assets807.59+15.2%792.13+15.0%718.76+4.7%729.32+3.1%701.14-3.4%688.63+1.6%686.29+8.7%707.34+10.2%
Net Property, Plant & Equipment707.95+21.8%722.54+22.3%560.95+1.1%569.90-0.5%581.16+1.5%590.71+2.8%554.79-7.0%572.66-8.9%
Total Investments and Advances6.37-42.9%6.55-35.3%7.63-24.0%14.22+91.6%11.16+42.2%10.13+28.9%10.04+24.6%7.42-41.4%
Intangible Assets795.54+2.3%795.80+2.8%776.31-63.8%774.09-73.0%777.52-73.4%773.77-73.5%2,147.00-27.0%2,867.24-3.2%
Deferred Tax Assets-28.04-33.8%---42.34-62.7%--
Other Assets10.51-9.9%10.98-0.9%11.07+120.1%11.07+117.1%11.66+118.4%11.08+105.6%5.03-10.3%5.10-45.8%
Total Assets2,327.95+11.8%2,356.05+11.3%2,074.72-39.0%2,098.60-49.9%2,082.65-51.1%2,116.66-51.2%3,403.15-19.2%4,191.75-3.2%
Short Term Debt Incl. Current Port. of LT Debt95.27+198.1%40.29+39.5%33.55+10.9%32.89-18.1%31.96-19.8%28.89-25.8%30.25-74.0%40.16-75.9%
Accounts Payable133.60+20.6%114.54+6.7%115.33+16.6%114.50+15.6%110.80+8.8%107.35+1.9%98.91+9.7%99.08+12.1%
Income Tax Payable15.60+1400.0%12.67+21016.7%0.00-100.0%1.91+38.4%1.04+7.2%0.06-98.5%1.50+4.2%1.38-57.5%
Other Current Liabilities186.21+50.4%190.88+32.5%108.66-17.4%110.02-20.2%123.83-17.9%144.01-4.5%131.51+8.4%137.91+0.8%
Total Current Liabilities430.69+60.9%358.38+27.9%257.54-1.8%259.31-6.9%267.63-8.8%280.30-6.3%262.17-20.3%278.52-29.5%
Long Term Debt276.66-5.2%358.11+19.4%283.53-9.6%286.74-14.1%291.79-16.3%299.85-13.9%313.66-14.2%333.63-8.0%
Provision for Risks Charges0.000.000.000.000.000.000.000.00
Deferred Tax Liabilities9.75+402.6%40.29-12.6%7.88-93.6%5.62-95.5%1.94-98.6%46.09-81.1%123.94-23.0%125.97-24.3%
Other Liabilities4.19+565.1%4.40+417.6%0.16-87.4%0.42+2000.0%0.63+530.0%0.85+844.4%1.27-91.1%0.02-99.8%
Total Liabilities721.28+28.3%761.18+21.4%549.12-21.7%552.09-25.2%561.99-27.8%627.09-29.7%701.04-19.4%738.15-21.2%
Non-Equity Reserves0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.00
Common Equity1,623.36+5.4%1,614.33+6.8%1,557.37-42.9%1,579.83-54.5%1,540.74-55.7%1,511.47-56.1%2,729.77-18.7%3,472.93+3.1%
Total Shareholders Equity1,623.36+5.4%1,614.33+6.8%1,557.37-42.9%1,579.83-54.5%1,540.74-55.7%1,511.47-56.1%2,729.77-18.7%3,472.93+3.1%
Accumulated Minority Interest-16.68-19.46-31.76-33.32-20.09-477.6%-21.90-8211.1%-27.67-19.32-177.2%
Total Equity1,606.67+5.7%1,594.87+7.1%1,525.61-43.5%1,546.51-55.2%1,520.66-56.3%1,489.58-56.7%2,702.10-19.2%3,453.61+1.8%
Total Liabilities & Stockholders Equity2,327.95+11.8%2,356.05+11.3%2,074.72-39.0%2,098.60-49.9%2,082.65-51.1%2,116.66-51.2%3,403.15-19.2%4,191.75-3.2%
Book Value Per Share per share11.29-18.3%12.31-13.8%13.40-52.2%13.60-63.8%13.82-65.2%14.28-65.5%28.03-35.4%37.52-18.4%
Tangible Book Value Per Share per share5.76-15.8%6.24-10.5%6.72+12.4%6.93+6.0%6.84+7.0%6.97+11.9%5.98+10.5%6.54+18.3%
Full-Time Employees people-3,595+26.5%---2,842+7.2%--
Price to Book Ratio ratio0.220.410.580.590.970.150.260.34
Return on Assets %-7.45-5.43-49.09-67.01-67.71-67.79-24.83-5.84
Return on Equity %-10.38-7.77-62.73-83.42-85.59-88.27-31.06-7.28
Return on Invested Capital %-2.27-2.51-1.44-2.41-0.02-70.27-25.94-2.24
Quick Ratio ratio1.111.371.661.721.561.491.611.58
Current Ratio ratio1.882.212.792.812.622.462.622.54

Cash flow, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q18/31/20262025Q45/31/20262025Q32/28/20262025Q211/30/20252025Q18/31/20252024Q45/31/20252024Q32/28/20252024Q211/30/2024
Net Income-40.03-2751.0%-38.07-25.85-43.171.51-1,275.32-768.74-85.06
Depreciation18.64+19.8%19.41-45.7%17.20-44.4%15.70-53.7%15.56-51.1%35.73+17.3%30.94-8.4%33.93+10.1%
Other Funds (Non Cash)10.8111.84-99.1%10.19-98.6%23.18-16.0%-6.38-262.8%1,359.96+5408.1%728.16+790.5%27.58+1989.4%
Funds from Operations-8.86-205.4%7.093.54-0.758.41+476.0%-2.29-120.9%-8.55-254.9%-22.40
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital-7.68-44.56-25.69-625.4%-7.71-9.75-12.00-159.6%4.89-18.19
Cash from Operating Activities-16.54-37.47-22.15-8.46-1.34-14.28-145.9%-3.66-40.59
Capital Expenditures-11.01-10.19-3.87-9.54-9.52-6.79-13.71-5.41
Net Assets From Acquisitions-0.72-53.920.00-100.0%0.000.00-0.25-139.7%0.47-18.18
Sale of Fixed Assets and Businesses0.10-65.5%1.72-71.1%1.38+666.7%0.13-78.3%0.29+866.7%5.96-18.0%0.18-77.8%0.60+2900.0%
Purchase or Sale of Investments2.38-92.9%11.00-17.5%31.11+114.8%-48.32-490.6%33.7013.34-70.6%14.48-62.5%12.37-92.7%
Purchase of Investments0.000.00-100.0%10.01-30.9%-13.63-210.2%-1.0013.3414.4812.37-72.8%
Sale Or Maturity of Investments2.38-93.1%11.0021.10-34.7034.700.00-100.0%0.00-100.0%0.00-100.0%
Other Uses0.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.00
Cash from Investing Activities-9.25-137.8%-51.39-519.5%28.63+1916.2%-57.7324.4712.25-72.0%1.42-95.1%-10.62-113.1%
Cash Dividends Paid0.000.000.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.000.000.00
Change in Capital Stock22.34-0.7%85.25+255.5%0.93-96.2%52.32+16.7%22.49-66.2%23.98+180.5%24.5944.85
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.00
Sale of Common Pref Stock22.34-0.7%85.25+255.5%0.93-96.2%52.32+16.7%22.49-66.2%23.98+180.5%24.5944.85
Proceedsfrom Stock Options22.34-0.7%85.25+255.5%0.90-96.3%49.97+11.4%22.49-66.2%23.98+180.5%24.5944.85
Issuance or Reduction of Debt, Net-5.93-14.36-4.05-3.79-1.65-3.32-8.75-5.96
Change in Long Term Debt-5.85-14.30-4185.7%-4.34-4.16-2.650.35-1.94-5.58
Issuance of Long Term Debt0.000.00-100.0%0.00-100.0%0.000.000.073.36+354.1%0.00-100.0%
Reduction of Long Term Debt-5.85-14.30-5031.0%-4.34-4.16-2.650.29-5.30-5.58
Net Financing Active Other Cash Flow0.000.00-0.160.000.00-1.530.000.00
Other Financing Activities Uses0.000.00-0.160.000.00-1.530.000.00
Cash from Financing Activities13.97-29.6%68.44+264.6%-4.31-128.6%47.55+25.0%19.85-67.2%18.77+138.5%15.0538.03
Exchange Rate Effect0.83+336.8%0.17-96.0%0.970.310.19-80.2%4.26-1.85-2.24-2588.9%
Net Change in Cash-11.00-125.5%-20.25-196.5%3.12-71.6%-18.3343.1620.99-74.4%10.97+2284.8%-15.42
Free Cash Flow-27.55-47.66-26.02-18.00-10.86-21.08-197.3%-17.37-46.00

Revenue breakdown

USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.

Product
Name20242025vs 20242025 share
Total Medicinal Chemicals & Botanical Products revenue821.31915.45+11.5%100.0%
Total821.31915.45+11.5%100.0%
Region
Name20242025vs 20242025 share
Canada212.86215.66+1.3%23.6%
EMEA323.35445.70+37.8%48.7%
Rest of World11.4011.71+2.6%1.3%
United States273.70242.39-11.4%26.5%
Total821.31915.45+11.5%100.0%
Segment
Name20242025vs 20242025 share
Beverage Alcohol Business240.60253.98+5.6%27.7%
Cannabis249.00268.34+7.8%29.3%
Distribution Business271.23327.24+20.7%35.7%
Wellness Business60.4965.89+8.9%7.2%
Total821.31915.45+11.5%100.0%

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3013.43%19.5M145.4M4.06M
2026-10-1514.80%21.5M145.4M4.21M
2026-09-3012.94%18.8M145.2M4.06M
2026-09-1514.58%19.4M133.2M4.03M
2026-08-3113.56%18.1M133.2M4.04M
2026-08-1413.76%18.4M134.0M4.00M
2026-07-3115.60%20.8M133.7M3.98M
2026-07-1513.62%16.2M119.1M4.99M
2026-06-3014.94%17.8M119.1M4.87M
2026-06-1515.40%18.3M118.7M4.66M
2026-05-2913.04%15.5M118.7M4.50M
2026-05-1514.16%16.8M118.7M4.41M
2026-04-3016.36%19.4M118.7M4.23M
2026-04-1512.44%14.4M115.6M2.95M
2026-03-3112.32%14.3M115.6M3.64M
2026-03-1313.33%15.4M115.6M7.48M
2026-02-2714.42%16.7M115.6M9.50M
2026-02-1312.85%14.9M115.6M9.75M
2026-01-3013.71%15.9M115.6M9.90M
2026-01-1513.12%15.2M115.6M10.30M

Option chain

expiry 2026-11-13
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call0.501.933.402.05-29.0012.000.990-0.0350.000
call1.001.412.921.52-80.0012.000.981-0.0340.000
call1.500.661.891.00-34.002.000.969-0.0310.000
call2.000.240.700.52-14.001.000.829-0.1030.000
call2.500.040.060.06-2322140.489-0.0390.000
call3.000.000.010.01-3,36342.000.076-0.0260.000
call3.500.000.010.01-1,5530.000.052-0.0310.000
call4.000.000.010.01-4270.000.042-0.0290.000
call4.500.000.010.01-79.000.000.037-0.0170.000
call5.000.000.010.01-63.000.000.033-0.0180.000
call5.500.000.010.01-10363.000.031-0.0400.000
call6.000.000.030.02-32051.000.029-0.0380.000
call6.500.002.130.01-2050.000.027-0.0410.000
call7.000.002.130.01-5280.000.026-0.0420.000
call7.500.000.010.01-2080.000.025-0.0440.000
put0.500.000.010.02-1.000.00-0.010-0.0350.000
put1.000.000.010.01-1.001.00-0.019-0.0280.000
put1.500.000.010.06-1.001.00-0.031-0.0260.000
put2.000.000.210.01-21.004.00-0.171-0.1020.000
put2.500.000.070.06-296280-0.511-0.0390.000
put3.000.450.540.53-53714.00-0.924-0.0260.000
put3.500.572.141.01-10.0015.00-0.948-0.0310.000
put4.000.473.001.56-22.005.00-0.958-0.0340.000
put4.501.363.801.98-7.004.00-0.963-0.0360.000
put5.000.914.102.57-22.009.00-0.967-0.0380.000
put5.502.484.753.00-8.001.00-0.969-0.0390.000
put6.002.174.853.57-2.004.00-0.971-0.0400.000
put6.503.104.904.00-8.003.00-0.973-0.0410.000
put7.004.005.154.50-2.000.00-0.974-0.0420.000
put7.504.455.655.08-1.001.00-0.975-0.0430.000

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-0810-QQuarterly report pursuant to Section 13 or 15(d)2026-08-31SEC
2026-10-088-KCurrent report2026-10-08SEC
2026-09-28ARSAnnual report to security holders. 2026-05-31SEC
2026-09-28DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-09-28DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-11-18SEC
2026-09-18PRE 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-11-18SEC
2026-09-148-KCurrent report2026-09-08SEC
2026-08-274Statement of changes in beneficial ownership of securities2026-08-26SEC
2026-08-274Statement of changes in beneficial ownership of securities2026-08-26SEC
2026-08-274Statement of changes in beneficial ownership of securities2026-08-26SEC
2026-08-274Statement of changes in beneficial ownership of securities2026-08-26SEC
2026-08-108-KCurrent report2026-08-04SEC
2026-08-074Statement of changes in beneficial ownership of securities2026-08-06SEC
2026-08-044Statement of changes in beneficial ownership of securities2026-08-04SEC
2026-08-044Statement of changes in beneficial ownership of securities2026-08-03SEC
2026-07-314Statement of changes in beneficial ownership of securities2026-07-29SEC
2026-07-314Statement of changes in beneficial ownership of securities2026-07-29SEC
2026-07-314Statement of changes in beneficial ownership of securities2026-07-29SEC
2026-07-314Statement of changes in beneficial ownership of securities2026-07-29SEC
2026-07-31S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-07-304Statement of changes in beneficial ownership of securities2026-07-29SEC
2026-07-304Statement of changes in beneficial ownership of securities2026-07-29SEC
2026-07-304Statement of changes in beneficial ownership of securities2026-07-29SEC
2026-07-304Statement of changes in beneficial ownership of securities2026-07-29SEC
2026-07-304Statement of changes in beneficial ownership of securities2026-07-29SEC
2026-07-304Statement of changes in beneficial ownership of securities2026-07-29SEC
2026-07-2810-KAnnual report pursuant to Section 13 or 15(d)2026-05-31SEC
2026-07-288-KCurrent report2026-07-28SEC
2026-06-308-KCurrent report2026-06-24SEC
2026-06-098-KCurrent report2026-06-03SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-0869.23K300
2026-070000
2026-060000
2026-050000
2026-0400232.88K1
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Tidal Investments LLC2.08%
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.85%
UBS Group AG0.85%
MORGAN STANLEY0.83%
CITADEL ADVISORS LLC0.72%
Point72 Asset Management, L.P.0.54%
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.0.54%
AQR CAPITAL MANAGEMENT LLC0.43%
BlackRock, Inc.0.38%
LAZARD ASSET MANAGEMENT LLC0.33%

Funds

Fund% owned
Amplify Alternative Harvest ETF2.06%
VANGUARD HEALTH CARE INDEX FUND0.26%
iShares U.S. Small-Cap Equity Factor ETF0.06%
AdvisorShares Pure Cannabis ETF0.06%
Dimensional International Small Cap ETF0.06%
State Street(R) SPDR(R) S&P(R) International Small Cap ETF0.05%
Fidelity MSCI Health Care Index ETF0.04%
The Canadian Small Company Series0.03%
Fidelity Nasdaq Composite Index ETF0.03%
World ex U.S. Core Equity Portfolio0.03%

OakChart. TLRY. Cached 15 minutes. Terms